Mengjun Wang

机构：Hubei University of Medicine, Medical University of South Carolina, Henan University of Technology · ORCID：0000-0002-8571-3530

发表论文 80 篇 · 总被引 1899 次 · h-index 24

代表论文

• New Insights into Mitochondria in Health and Diseases (2024 · International Journal of Molecular Sciences · 被引 40)
• USP32 deubiquitinase: cellular functions, regulatory mechanisms, and potential as a cancer therapy target (2023 · Cell Death Discovery · 被引 34)
• Bufalin targeting CAMKK2 inhibits the occurrence and development of intrahepatic cholangiocarcinoma through Wnt/β-catenin signal pathway (2023 · Journal of Translational Medicine · 被引 29)
• Quantification and visualization of hydrogen peroxide in an ischemic model and serum samples from stroke patients using a reaction-based fluorescence sensor (2023 · Sensors and Actuators B Chemical · 被引 19)
• USP32 facilitates non-small cell lung cancer progression via deubiquitinating BAG3 and activating RAF-MEK-ERK signaling pathway (2024 · Oncogenesis · 被引 18)
• Effects of microgels fabricated by microfluidic on the stability, antioxidant, and immunoenhancing activities of aquatic protein (2024 · Journal of Future Foods · 被引 14)